These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3494963)
1. Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Perry TL; Hansen S; Jones K Neurosci Lett; 1987 Feb; 74(2):217-20. PubMed ID: 3494963 [TBL] [Abstract][Full Text] [Related]
2. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1). Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428 [TBL] [Abstract][Full Text] [Related]
3. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl. Saitoh T J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627 [TBL] [Abstract][Full Text] [Related]
4. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse. Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525 [TBL] [Abstract][Full Text] [Related]
6. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice. Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC Neuropharmacology; 1984 Jun; 23(6):711-3. PubMed ID: 6611514 [TBL] [Abstract][Full Text] [Related]
7. Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice. Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A Neuropharmacology; 1986 Aug; 25(8):927-30. PubMed ID: 3490630 [TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment. Shahi GS; Das NP; Moochhala SM Neurosci Lett; 1991 Jun; 127(2):247-50. PubMed ID: 1881637 [TBL] [Abstract][Full Text] [Related]
9. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP]. Averkin RG; Korshunov VA; ShchegolevskiÄ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690 [TBL] [Abstract][Full Text] [Related]
10. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity. Mayer RA; Walters AS; Heikkila RE Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908 [TBL] [Abstract][Full Text] [Related]
11. 2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease. Perry TL; Jones K; Hansen S; Wall RA J Neurol Sci; 1988 Jul; 85(3):309-17. PubMed ID: 3210027 [TBL] [Abstract][Full Text] [Related]
12. Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse. Sershen H; Hashim A; Wiener HL; Lajtha A Neurosci Lett; 1988 Nov; 93(2-3):270-4. PubMed ID: 3266524 [TBL] [Abstract][Full Text] [Related]
13. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat. Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293 [TBL] [Abstract][Full Text] [Related]
14. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets. Perry TL; Jones K; Hansen S; Wall RA Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859 [TBL] [Abstract][Full Text] [Related]